Galectin Therapeutics reported $-12.37M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Galectin Therapeutics USD -12.37M 880K Jun/2024
Gilead Sciences USD -7.53B 10.11B Jun/2026
Immunic USD -19.3M 6.28M Dec/2025
Incyte USD 751.51M 407.91M Jun/2026
Merck USD -3.53B 6.95B Mar/2026